Three Molecular Testing Companies Merge to Form OSPRI
Community Direct DX, Scienetix, and Advanta Genetics R&D combine with $30 million in funding to create a vertically integrated PCR testing platform.
Read MorePosted by CLP Edit Staff | Aug 19, 2025 | Molecular Diagnostic Analyzers |
Community Direct DX, Scienetix, and Advanta Genetics R&D combine with $30 million in funding to create a vertically integrated PCR testing platform.
Read MorePosted by CLP Edit Staff | Aug 18, 2025 | Dementias & Alzheimer’s |
The test offers a less invasive alternative to cerebrospinal fluid testing and PET scans for detecting amyloid plaques.
Read MorePosted by CLP Edit Staff | Aug 15, 2025 | Allergy & Autoimmune |
New research demonstrates BAT outperforms standard allergy tests in children under 2, potentially reducing need for oral food challenges by nearly half.
Read MorePosted by CLP Edit Staff | Aug 15, 2025 | Cancer |
Dana-Farber Cancer Institute, Boston Children’s Hospital, and Broad Clinical Labs form BrightSeq collaborative to develop novel clinical diagnostic assays for rare pediatric cancers.
Read MorePosted by Alyx Arnett | Aug 14, 2025 | Cervical (HPV) |
This marks the first time a US Food and Drug Adminstration-authorized self-collection device is available for at-home cervical cancer screening in the US.
Read More